| JYHZ2500096 | 多替拉韦钠片 | | Tablet | Chemical Drugs | License Renew | 2025-04-24 | | GlaxoSmithKline (China) Investment Co Ltd;Viiv Healthcare BV;Delpharm Poznan SA | | | view |
| JYHZ2000189 | 多替拉韦钠片 | | Tablet | Chemical Drugs | License Renew | 2020-08-10 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Viiv Healthcare BV;Glaxo Operations UK Ltd | Certificate Issued | 2021-02-22 | view |
| JYHZ2000188 | 多替拉韦钠片 | | Tablet | Chemical Drugs | License Renew | 2020-08-10 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Viiv Healthcare BV;Glaxo Operations UK Ltd | Certificate Issued | 2021-02-22 | view |
| JYHZ2000175 | 多替拉韦钠片 | | Tablet | Chemical Drugs | License Renew | 2020-07-11 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Viiv Healthcare BV;Glaxo Operations UK Ltd | Certificate Issued | 2020-12-22 | view |
| JYHS2400014 | 多替拉韦钠片 | | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2024-04-02 | | Hetero Labs Ltd;Hetero Phrma (Beijing) Co Limited | | | view |
| JYHB2500083 | 多替拉韦钠片 | | Tablet | Chemical Drugs | Supplementary Application | 2025-02-20 | | Viiv Healthcare BV;Glaxo Operations UK Ltd | | | view |
| JYHB2500082 | 多替拉韦钠片 | | Tablet | Chemical Drugs | Supplementary Application | 2025-02-20 | | Viiv Healthcare BV;Glaxo Operations UK Ltd | | | view |
| JYHB2500016 | 多替拉韦钠片 | | Tablet | Chemical Drugs | Supplementary Application | 2025-01-10 | | Viiv Healthcare BV;Delpharm Poznan SA | | | view |
| JYHB2400126 | 多替拉韦钠片 | | Tablet | Chemical Drugs | Supplementary Application | 2024-03-15 | | Viiv Healthcare BV;Glaxo Operations UK Ltd | | | view |
| JYHB2400125 | 多替拉韦钠片 | | Tablet | Chemical Drugs | Supplementary Application | 2024-03-15 | | Viiv Healthcare BV;Glaxo Operations UK Ltd | | | view |
| JYHB2300538 | 多替拉韦钠片 | | Tablet | Chemical Drugs | Supplementary Application | 2023-09-20 | | Viiv Healthcare BV;Delpharm Poznan SA | | | view |
| JYHB2300045 | 多替拉韦钠片 | | Tablet | Chemical Drugs | Supplementary Application | 2023-01-13 | | Viiv Healthcare BV;Glaxo Operations UK Ltd | | | view |
| JYHB2300044 | 多替拉韦钠片 | | Tablet | Chemical Drugs | Supplementary Application | 2023-01-13 | | Viiv Healthcare BV;Glaxo Operations UK Ltd | | | view |
| JYHB2200686 | 多替拉韦钠片 | | Tablet | Chemical Drugs | Supplementary Application | 2022-12-31 | | Viiv Healthcare BV;Delpharm Poznan SA | | | view |
| JYHB2101115 | 多替拉韦钠片 | | Tablet | Chemical Drugs | Supplementary Application | 2021-05-26 | | Viiv Healthcare BV;Glaxo Operations UK Ltd | | | view |
| JYHB2101107 | 多替拉韦钠片 | | Tablet | Chemical Drugs | Supplementary Application | 2021-05-20 | | Viiv Healthcare BV;Glaxo Operations UK Ltd | | | view |
| JYHB2101106 | 多替拉韦钠片 | | Tablet | Chemical Drugs | Supplementary Application | 2021-05-20 | | Viiv Healthcare BV;Glaxo Operations UK Ltd | | | view |
| JYHB2002628 | 多替拉韦钠片 | | Tablet | Chemical Drugs | Supplementary Application | 2020-12-21 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Viiv Healthcare BV;Glaxo Operations UK Ltd | Filed | 2020-12-29 | view |
| JYHB2002627 | 多替拉韦钠片 | | Tablet | Chemical Drugs | Supplementary Application | 2020-12-21 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Viiv Healthcare BV;Glaxo Operations UK Ltd | Filed | 2020-12-29 | view |
| JYHB2001841 | 多替拉韦钠片 | | Tablet | Chemical Drugs | Supplementary Application | 2020-09-22 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Viiv Healthcare BV;Glaxo Operations UK Ltd | Filed | 2020-10-12 | view |
